The typical autologous T-cell therapy workflow is a very complex and labor-intensive process with multiple stages where contamination and errors can greatly affect the desired outcome. In this infoposter we:
- Explore how closed, modular cell therapy workflows have the potential to overcome manufacturing hurdles
- Discuss how this closed-system approach could result in a reduction in touchpoints
- Guide you through a typical vein-to-vein process
To learn more, download our infoposter below.